We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-5.21%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$6.31B
AUM Growth
-$1.31B
Cap. Flow
-$452M
Cap. Flow %
-7.17%
Top 10 Hldgs %
37.6%
Holding
304
New
27
Increased
63
Reduced
157
Closed
47

Top Buys

Rank Stock Value
1
TWOU
2U Inc
TWOU
+$75.8M
2
ADPT
Adeptus Health Inc
ADPT
+$73.7M
3
SHAK icon
Shake Shack
SHAK
+$53.8M
4
ULTA icon
Ulta Beauty
ULTA
+$45.2M
5
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$43.1M

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$61.2M
2
TWTR
Twitter, Inc.
TWTR
+$55.8M
3
ESPR
Esperion Therapeutics
ESPR
+$51.1M
4
JD icon
JD.com
JD
+$50.8M
5
ZG icon
Zillow
ZG
+$45.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.45%
2 Healthcare 20.34%
3 Communication Services 17.82%
4 Technology 17.65%
5 Miscellaneous 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLMBP
251
SLM Corp Series B
SLMBP
$185M
$15K ﹤0.01%
300
-83
-22% -$4.56K
ALTO icon
252
Alto Ingredients
ALTO
$307M
$14K ﹤0.01%
2,218
– –
UPLD icon
253
Upland Software
UPLD
$9.52M
$13K ﹤0.01%
165
– –
SIOX
254
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$13K ﹤0.01%
125
– –
BID
255
DELISTED
Sotheby's
BID
$13K ﹤0.01%
391
-538,461
-100% -$20.6M
AMBA icon
256
Ambarella
AMBA
$2.82B
– –
-189
Closed -$19K
ASMB icon
257
Assembly Biosciences
ASMB
$590M
– –
-5,135
Closed -$1.19M
BABA icon
258
Alibaba
BABA
$272B
– –
-119,565
Closed -$9.84M
BIIB icon
259
Biogen
BIIB
$32.1B
– –
-1,062
Closed -$429K
BOOT icon
260
Boot Barn
BOOT
$4.33B
– –
-829,508
Closed -$26.5M
BPMC
261
DELISTED
Blueprint Medicines
BPMC
– –
-4,710
Closed -$125K
CGNX icon
262
Cognex
CGNX
$10.1B
– –
-334,646
Closed -$8.05M
CRDF icon
263
Cardiff Oncology
CRDF
$102M
– –
-526
Closed -$384K
CRTO icon
264
Criteo S.A.
CRTO
$855M
– –
-5,901
Closed -$281K
CSTE icon
265
Caesarstone
CSTE
$110M
– –
-186,640
Closed -$12.8M
FRPT icon
266
Freshpet
FRPT
$3.06B
– –
-98,929
Closed -$1.84M
GLD icon
267
SPDR Gold Trust
GLD
$145B
– –
-647
Closed -$73K
IMUX icon
268
Immunic
IMUX
$153M
– –
-82
Closed -$692K
INSG icon
269
Inseego
INSG
$73.4M
– –
-31,498
Closed -$1.02M
LNG icon
270
Cheniere Energy
LNG
$56.6B
– –
-4,094
Closed -$284K
MGA icon
271
Magna International
MGA
$17.4B
– –
-124,991
Closed -$7.01M
MMYT icon
272
MakeMyTrip
MMYT
$4.75B
– –
-122,693
Closed -$2.42M
NVAX icon
273
Novavax
NVAX
$1.58B
– –
-5,385
Closed -$1.2M
NXPI icon
274
NXP Semiconductors
NXPI
$56.5B
– –
-8,594
Closed -$844K
ODFL icon
275
Old Dominion Freight Line
ODFL
$37.7B
– –
-62,244
Closed -$1.42M
9 10
11
12 13

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Gilder Gagnon Howe & Co held 304 positions worth $6.31B, down 17% from $7.61B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $452M in Q3 2015, closing 47 positions and reducing 157 holdings. Its most notable exit was Silicon Laboratories, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Adeptus Health Inc worth $57.7M.

  • Gilder Gagnon Howe & Co's largest Q3 2015 buy was Adeptus Health Inc: 714,509 shares worth $57.7M.
  • Gilder Gagnon Howe & Co added most to 2U Inc in Q3 2015, an estimated $75.8M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2015 reduction was Akamai, cutting an estimated $61.2M.
  • Gilder Gagnon Howe & Co fully exited Silicon Laboratories in Q3 2015, selling an estimated $28.1M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 38% of its $6.31B portfolio in Q3 2015.
  • Gilder Gagnon Howe & Co opened 27 new positions and closed 47 in Q3 2015.
  • Gilder Gagnon Howe & Co's portfolio value fell 17% quarter-over-quarter to $6.31B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2015, filed 9 Nov 2015.